$123 Million is the total value of PALLADIEM, LLC's 182 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 30.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BND | Buy | VANGUARD BD INDEX FD INCtotal bnd mkt | $10,717,000 | +1409.4% | 128,550 | +1391.3% | 8.75% | +1403.1% |
| CSM | Buy | PROSHARES TR | $7,580,000 | +10.4% | 75,430 | +10.9% | 6.19% | +10.0% |
| SHY | Buy | ISHARES TR1-3 yr tr bd etf | $5,400,000 | +1.8% | 63,620 | +1.3% | 4.41% | +1.4% |
| MDIV | Buy | FIRST TR EXCHANGE TRADED FDmulti asset di | $5,070,000 | +0.5% | 240,725 | +1.5% | 4.14% | +0.1% |
| FXH | Buy | FIRST TR EXCHANGE TRADED FDconsumr discre | $2,392,000 | +15.1% | 35,686 | +3.5% | 1.95% | +14.7% |
| RALS | Buy | PROSHARES TRrafi lg sht fd | $2,242,000 | -1.3% | 55,305 | +2.6% | 1.83% | -1.7% |
| SUSA | Buy | ISHARESusa esg slct etf | $1,579,000 | -0.1% | 18,387 | +0.2% | 1.29% | -0.5% |
| IGF | Buy | ISHARESglb infrastr etf | $1,024,000 | +12.9% | 24,469 | +13.7% | 0.84% | +12.5% |
| ALTS | Buy | PROSHARES TRaltrntv solutn | $946,000 | +350.5% | 23,295 | +355.0% | 0.77% | +348.8% |
| TBT | New | PROSHARES TR | $89,000 | – | 2,125 | +100.0% | 0.07% | – |
| HDV | Buy | ISHARES TRcore high div etf | $90,000 | +63.6% | 1,200 | +65.5% | 0.07% | +62.2% |
| WDIV | New | SPDR INDEX SHS FDSs&p glb div etf | $77,000 | – | 1,170 | +100.0% | 0.06% | – |
| MDT | New | Medtronic Inc | $74,000 | – | 953 | +100.0% | 0.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-04-24
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corporation | 16 | Q3 2023 | 1.2% |
| NOVO-NORDISK A S ADR | 16 | Q3 2023 | 0.5% |
| UNILEVER PLC SPON ADR | 16 | Q3 2023 | 0.3% |
| COCA COLA CO | 16 | Q3 2023 | 0.3% |
| MCDONALDS CORP | 16 | Q3 2023 | 0.3% |
| ING GROUP N V | 16 | Q3 2023 | 0.3% |
| INDEXIQ ETF TR IQ ARB MRG ETF | 15 | Q2 2023 | 1.6% |
| Procter & Gamble Co | 15 | Q3 2023 | 0.4% |
| NOVARTIS A G SPONSORED ADR | 15 | Q3 2023 | 0.3% |
| SPDR TR UNIT SER 1 | 12 | Q3 2023 | 3.9% |
View PALLADIEM, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Virtus ETF Trust II | July 13, 2021 | 58,890 | 19.6% |
| DBX ETF TRUST | October 28, 2020 | 56,655 | 11.3% |
| DBX ETF TRUST | April 01, 2020 | 168,673 | 5.9% |
| SPDR SERIES TRUST | February 04, 2015 | 71,400 | 5.1% |
View PALLADIEM, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-12-08 |
| 13F-HR | 2023-12-08 |
| 13F-HR | 2023-05-04 |
| 13F-HR | 2023-02-02 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-07-26 |
| 13F-HR | 2022-04-22 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-10 |
| 13F-HR | 2021-07-14 |
View PALLADIEM, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.